M.D. Anderson Cancer Center: Oropharyngeal Neoplasms trials

The registry lists 22 Oropharyngeal Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 4 are open to participants now and 5 have results posted.

Phase 1 2Phase 2 9Phase 3 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)Not yet recruitingNCT07832266Phase 1
• High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer SurvivorsRecruitingNCT04151082Phase 1/2
• Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck CancerRecruitingNCT03010150
• Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"RecruitingNCT01365169Not applicable
• Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell CarcinomaTerminatedNCT03799445Phase 2Results posted
• Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal CancerTerminatedNCT03258008Phase 2Results posted
• Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.CompletedNCT01173692Phase 2Results posted
• OraTest in Combination With Visual Examination and Visual Examination AloneTerminatedNCT00537199Phase 3Results posted
• A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck CancerCompletedNCT00490282Not applicableResults posted
• Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)Active, not recruitingNCT06167291Phase 2
• Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell CarcinomaWithdrawnNCT05535023Phase 2
• BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer PatientsWithdrawnNCT05363709Phase 2
• Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal CancerActive, not recruitingNCT04874493
• Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal CancerActive, not recruitingNCT03224000Phase 2
• Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer PatientsActive, not recruitingNCT02253238Not applicable
• Robotic Surgery for Oropharyngeal Squamous Cell CarcinomaTerminatedNCT02225496Phase 2
• Controlled Trial Of Acupuncture To Prevent Radiation-Induced XerostomiaActive, not recruitingNCT01266044Phase 3
• Complete Decongestive Therapy (CDT) for Treatment of Head and Neck LymphedemaWithdrawnNCT00951470Not applicable
• Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation TherapyWithdrawnNCT00928161Not applicable
• Sexual Behavior in Head and Neck Cancer PatientsStatus unknownNCT00662662
• Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV InfectionCompletedNCT00508170
• Depression and Adherence in Head and Neck CancerActive, not recruitingNCT00498875